Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (183 ops.)
Latest filing published 21 Oct 2026 for Adaptive Biotechnologies Corp, €128k.
Filing timeline
BuySaleJulie Rubinstein
First 200 filings with a declared amount
Insider track record
Disclosed buys
0
Disclosed sells
183
Signal history
Julie Rubinstein: trading record in brief
Julie Rubinstein, listed as senior executive, appears in our data through filings on Adaptive Biotechnologies Corp shares, published by SEC (Form 4). In total, 292 filings cover trades dated from 24 December 2019 to 21 October 2026.
Every open-market trade on record is a sale: 183 sales worth €66.3M. The rest of the record consists of 6 share grants and 103 option exercises. In 2026 alone, the filings show no purchases and 37 sales.
The latest filing, published on 21 October 2026, reports an option exercise of €128k in Adaptive Biotechnologies Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Julie Rubinstein
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations292 total
11,881 shares@ US$12.14Common StockSEC:0001780664-26-000043:0
11,881 shares@ US$24.05Common StockSEC:0001780664-26-000043:1
11,881 shares@ US$12.14Common StockSEC:0001780664-26-000043:2
11,781 shares@ US$24.53Common StockSEC:0001780664-26-000043:3
100 shares@ US$24.85Common StockSEC:0001780664-26-000043:4
11,881 shares@ US$12.14Common StockSEC:0001780664-26-000043:5
5,999 shares@ US$25.25Common StockSEC:0001780664-26-000043:6
5,882 shares@ US$25.57Common StockSEC:0001780664-26-000043:7
11,881 shares@ US$12.140.0035% mcap1.1% of flowCommon StockSEC:0001780664-26-000041:0
6,781 shares@ US$25.570.0042% mcap1.4% of flowCommon StockSEC:0001780664-26-000041:1
11,881 shares@ US$12.140.0035% mcap1.1% of flowCommon StockSEC:0001780664-26-000041:3
11,881 shares@ US$12.140.0035% mcap1.1% of flowCommon StockSEC:0001780664-26-000041:5
11,581 shares@ US$24.210.0069% mcap2.2% of flowCommon StockSEC:0001780664-26-000041:6
11,881 shares@ US$25.610.0074% mcap2.4% of flowCommon StockSEC:0001780664-26-000041:4
5,100 shares@ US$25.820.0032% mcap1.0% of flowCommon StockSEC:0001780664-26-000041:2
300 shares@ US$25.450.0002% mcap0.1% of flowCommon StockSEC:0001780664-26-000041:7
9,181 shares@ US$25.350.0057% mcap2.1% of flowCommon StockSEC:0001780664-26-000039:3
11,881 shares@ US$12.140.0035% mcap1.3% of flowCommon StockSEC:0001780664-26-000039:0
11,881 shares@ US$26.410.0076% mcap2.8% of flowCommon StockSEC:0001780664-26-000039:1
11,881 shares@ US$12.140.0035% mcap1.3% of flowCommon StockSEC:0001780664-26-000039:2
2,700 shares@ US$26.070.0017% mcap0.6% of flowCommon StockSEC:0001780664-26-000039:4
11,881 shares@ US$12.140.0035% mcap1.3% of flowCommon StockSEC:0001780664-26-000039:5
11,881 shares@ US$25.500.0074% mcap2.7% of flowCommon StockSEC:0001780664-26-000039:6
11,881 shares@ US$12.140.0034% mcap1.5% of flowCommon StockSEC:0001780664-26-000037:0
9,381 shares@ US$27.360.0060% mcap2.6% of flowCommon StockSEC:0001780664-26-000037:1
25 of 292 declarations
